Shares of Agenus Inc. (NASDAQ: AGEN) closed the trading at a price of $2.42 with the positive change of +6.61%. In the past session approximately 1,038,662 shares were exchanged against the average daily trading volume of 1,558,179 shares. The stock touched to the maximum level of $2.43, and it reached the lower level of $2.23 in past session. The stock’s market capitalization has now valued at $251.678M. The stock’s low price in its 52 week is $2.13 per share while $6.19 as the 52 week high price. The last bid price was called at $0.00 x 1000 and the ask price was stated at $3.65 x 2900.
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, cancer vaccines and adoptive cell therapies1, provided a corporate update and stated financial results for the first quarter ending March 31, 2018.
1st Quarter 2018 Financial Results
Cash and cash equivalents were $52.3M and $60.2M at March 31, 2018 and December 31, 2017 respectively.
For the first quarter ended March 31, 2018, we stated research and development expenses of $29.4M, and $32.6M for the same period in 2017. Our net loss of for the three months ended March 31, 2018 is $54.3M or $0.53 per share contrast to a net loss for same period in 2017 of $17.1M, or $0.18 per share. The increased net loss reflects unfavorable items effecting the current quarter and favorable items effecting the same period last year; including, the loss on the extinguishment of our debt, increased change in the non-cash contingent considerations fair value adjustment as well as reduced revenue Because of an accelerated milestone received during the first quarter of 2017 from Incyte.
Agenus executives hosted a conference call on Monday, May 7, 2018 at 11:00 a.m.
Agenus is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body’s immune system to fight cancer.
Agenus Inc.’s (AGEN) stock price showed strong performance of 4.76% in last seven days, switched down -27.98% in last thirty days and it fell -38.11% in last one year.
It has 99.74 million of outstanding shares and its shares float measured at 75.81.